A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux

In order to study the importance of gastro-oesophageal reflux (GOR) as a trigger of asthma the effect of inhibition of gastric acid secretion on asthma was assessed in a double-blind, cross-over, placebo-controlled trial over four weeks in 37 children and adolescents (mean age 14 yrs) with bronchial asthma. Ranitidine 300 mg, (150 mg if B.W. was less than 40 kg) was given as a single evening dose during four weeks. In previous investigations 18 of the 37 patients had been shown to have pathological GOR by 24 h pH monitoring in the oesophagus. The remaining 19 patients with normal GOR served as controls for possible effects of ranitidine on asthma, not related to reduction of GOR. A modest (30%) but statistically significant reduction of nocturnal asthma symptoms was produced by ranitidine in the patients with pathological GOR when compared to those with normal GOR. There was a significant correlation between the improvement in asthma symptoms and the degree of acid reflux. Side-effects of ranitidine were negligible. Acid reflux appears to be only a weak stimulus for bronchoconstriction in children and adolescents with bronchial asthma and pathological GOR. Further confirmative trials with more potent inhibitors of gastric acid secretion are, however, warranted.

This article has been cited by other articles:

				M Ferrari, F Bonella, L Benini, P Ferrari, F De Iorio, R Testi, and V Lo Cascio Acid reflux into the oesophagus does not influence exercise-induced airway narrowing in bronchial asthma Br. J. Sports Med., October 1, 2008; 42(10): 545 - 549. [Abstract] [Full Text] [PDF]

				R. Rosen, J. Fritz, A. Nurko, D. Simon, and S. Nurko Lipid-Laden Macrophage Index Is Not an Indicator of Gastroesophageal Reflux-Related Respiratory Disease in Children Pediatrics, April 1, 2008; 121(4): e879 - e884. [Abstract] [Full Text] [PDF]

				J L Heraghty and A J Henderson Highlights in asthma 2005. Arch. Dis. Child., May 1, 2006; 91(5): 422 - 425. [Abstract] [Full Text] [PDF]

				K Stordal, G B Johannesdottir, B S Bentsen, P K Knudsen, K C L Carlsen, O Closs, M Handeland, H K Holm, and L Sandvik Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease Arch. Dis. Child., September 1, 2005; 90(9): 956 - 960. [Abstract] [Full Text] [PDF]

				J L Mathew, M Singh, and S K Mittal Gastro-oesophageal reflux and bronchial asthma: current status and future directions Postgrad. Med. J., December 1, 2004; 80(950): 701 - 705. [Abstract] [Full Text] [PDF]

				V. Khoshoo, T. Le, R. M. Haydel Jr, L. Landry, and C. Nelson Role of Gastroesophageal Reflux in Older Children With Persistent Asthma Chest, April 1, 2003; 123(4): 1008 - 1013. [Abstract] [Full Text] [PDF]

				J L Coughlan, P G Gibson, and R L Henry Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review Thorax, March 1, 2001; 56(3): 198 - 204. [Abstract] [Full Text]

				T. O. Kiljander, E.-R. M. Salomaa, E. K. Hietanen, and E. O. Terho Gastroesophageal Reflux in Asthmatics: A Double-Blind, Placebo-Controlled Crossover Study With Omeprazole Chest, November 1, 1999; 116(5): 1257 - 1264. [Abstract] [Full Text] [PDF]